As per Market Research Future (MRFR)’s latest analysis, the global neuropathic pain market is set to proliferate at a CAGR of 6.06% during the forecast period.

The rising prevalence of chronic diseases such as diabetes and cancer that triggers neuropathic pain is a major factor responsible for driving the growth of the market.